Xiang RF - Search Results

1

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.

Long J, Jia MY, Fang WY, Chen XJ, Mu LL, Wang ZY, Shen Y, Xiang RF, Wang LN, Wang L, Jiang CH, Jiang JL, Zhang WJ, Sun YD, Chang L, Gao WH, Wang Y, Li JM, Hong DL, Liang AB, Hu J. Long J, et al. Among authors: xiang rf. Blood. 2020 Apr 23;135(17):1472-1483. doi: 10.1182/blood.2019003538. Blood. 2020. PMID: 32315388 Free article.

2

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.

Xiang RF, Wang Y, Zhang N, Xu WB, Cao Y, Tong J, Li JM, Wu YL, Yan H. Xiang RF, et al. Cell Death Dis. 2017 May 11;8(5):e2776. doi: 10.1038/cddis.2017.188. Cell Death Dis. 2017. PMID: 28492559 Free PMC article.

3

The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review.

Jin Z, Xiang R, Qing K, Li X, Zhang Y, Wang L, Zhu H, Mao Y, Xu Z, Li J. Jin Z, et al. Ann Hematol. 2018 Aug;97(8):1327-1335. doi: 10.1007/s00277-018-3368-8. Epub 2018 May 15. Ann Hematol. 2018. PMID: 29766234

4

Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy.

Tong J, Xu X, Zhang Z, Ma C, Xiang R, Liu J, Xu W, Wu C, Li J, Zhan F, Wu Y, Yan H. Tong J, et al. Haematologica. 2020 Jun;105(6):1630-1640. doi: 10.3324/haematol.2019.218289. Epub 2019 Jul 9. Haematologica. 2020. PMID: 31289203 Free PMC article.

5

Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.

Li R, Ding Z, Jin P, Wu S, Jiang G, Xiang R, Wang W, Jin Z, Li X, Xue K, Wu X, Li J. Li R, et al. Front Immunol. 2021 May 5;12:639634. doi: 10.3389/fimmu.2021.639634. eCollection 2021. Front Immunol. 2021. PMID: 34025649 Free PMC article.

6

Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Qing K, Jin Z, Xu Z, Wang W, Li X, Zhang Y, Wang L, Zhu H, Xiang R, Wu S, Li R, Jiang G, Xue K, Li J. Qing K, et al. Chemotherapy. 2022;67(1):12-23. doi: 10.1159/000520070. Epub 2021 Nov 29. Chemotherapy. 2022. PMID: 34844236

7

Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma.

Jin Z, Xiang R, Qing K, Li D, Liu Z, Li X, Zhu H, Zhang Y, Wang L, Xue K, Liu H, Xu Z, Wang Y, Li J. Jin Z, et al. Cell Oncol (Dordr). 2023 Aug;46(4):1143-1157. doi: 10.1007/s13402-023-00833-6. Epub 2023 May 23. Cell Oncol (Dordr). 2023. PMID: 37219767

8

A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.

Long J, Chen X, Shen Y, Lei Y, Mu L, Wang Z, Xiang R, Gao W, Wang L, Wang L, Jiang J, Zhang W, Lu H, Dong Y, Ding Y, Zhu H, Hong D, Sun YE, Hu J, Liang A. Long J, et al. Cell Rep Med. 2023 Nov 21;4(11):101286. doi: 10.1016/j.xcrm.2023.101286. Epub 2023 Nov 10. Cell Rep Med. 2023. PMID: 37951217 Free PMC article.

9

A CD8⁺ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia.

Li Z, Jin P, Xiang R, Li X, Shen J, He M, Liu X, Zhu H, Wu S, Dong F, Zhao H, Liu H, Jin Z, Li J. Li Z, et al. Front Immunol. 2024 Sep 12;15:1408109. doi: 10.3389/fimmu.2024.1408109. eCollection 2024. Front Immunol. 2024. PMID: 39346926 Free PMC article.

10

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.

Yu W, Chen Y, Xiang R, Xu W, Wang Y, Tong J, Zhang N, Wu Y, Yan H. Yu W, et al. Leuk Lymphoma. 2017 Feb;58(2):428-437. doi: 10.1080/10428194.2016.1190968. Epub 2016 Jul 20. Leuk Lymphoma. 2017. PMID: 27439454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters